Compare QMCO & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QMCO | TKNO |
|---|---|---|
| Founded | 1980 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.5M | 111.9M |
| IPO Year | 2025 | 2021 |
| Metric | QMCO | TKNO |
|---|---|---|
| Price | $5.21 | $2.08 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 523.2K | 339.5K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $372,827,000.00 | $37,745,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | $1.99 | $9.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 6.65 | 2.89 |
| 52 Week Low | $4.89 | $1.91 |
| 52 Week High | $24.40 | $7.48 |
| Indicator | QMCO | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 33.06 | 22.26 |
| Support Level | $4.89 | N/A |
| Resistance Level | $8.27 | $5.39 |
| Average True Range (ATR) | 0.53 | 0.23 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 16.67 | 23.81 |
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.